Allison Bratzel
Stock Analyst at Piper Sandler
(4.85)
# 409
Out of 5,078 analysts
278
Total ratings
51.6%
Success rate
30%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Allison Bratzel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABVX ABIVAX Société Anonyme | Reiterated: Buy | $175 | $88.01 | +98.84% | 14 | Oct 21, 2026 | |
| AKBA Akebia Therapeutics | Reiterated: Buy | $4 | $0.5669 | +605.59% | 19 | Oct 21, 2026 | |
| ARDX Ardelyx | Reiterated: Buy | $15 | $3.08 | +387.01% | 10 | Oct 21, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $1,215 | $873.71 | +39.06% | 35 | Oct 21, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Buy | $90 | $55.95 | +60.86% | 10 | Oct 21, 2026 | |
| CDXS Codexis | Reiterated: Buy | $8 | $1.28 | +525.00% | 13 | Oct 21, 2026 | |
| INCY Incyte | Reiterated: Buy | $130 | $115.71 | +12.35% | 14 | Oct 21, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $94 → $87 | $42.93 | +102.66% | 15 | Oct 21, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Buy | $68 → $36 | $15.65 | +130.03% | 8 | Oct 21, 2026 | |
| RIGL Rigel Pharmaceuticals | Reiterated: Hold | $49 | $48.13 | +1.81% | 11 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $41.49 | +80.77% | 16 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 | $50.08 | +35.78% | 22 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $1.56 | +156.41% | 5 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 | $20.45 | +173.84% | 6 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.17 | +241.88% | 7 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $13.88 | +116.14% | 7 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 → $55 | $31.21 | +76.23% | 9 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $0.4354 | +129.67% | 10 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.73 | +221.72% | 6 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $9.21 | +225.73% | 7 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $11.82 | +1.52% | 7 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $11.46 | +22.16% | 10 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 → $0.5 | $0.0001 | +499,900.00% | 5 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $36.49 | n/a | 6 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $8 → $20 | $5.92 | n/a | 6 | Mar 14, 2024 |
ABIVAX Société Anonyme
Oct 21, 2026
Reiterated: Buy
Price Target: $175
Current: $88.01
Upside: +98.84%
Akebia Therapeutics
Oct 21, 2026
Reiterated: Buy
Price Target: $4
Current: $0.5669
Upside: +605.59%
Ardelyx
Oct 21, 2026
Reiterated: Buy
Price Target: $15
Current: $3.08
Upside: +387.01%
argenx SE
Oct 21, 2026
Reiterated: Buy
Price Target: $1,215
Current: $873.71
Upside: +39.06%
BioMarin Pharmaceutical
Oct 21, 2026
Reiterated: Buy
Price Target: $90
Current: $55.95
Upside: +60.86%
Codexis
Oct 21, 2026
Reiterated: Buy
Price Target: $8
Current: $1.28
Upside: +525.00%
Incyte
Oct 21, 2026
Reiterated: Buy
Price Target: $130
Current: $115.71
Upside: +12.35%
Ionis Pharmaceuticals
Oct 21, 2026
Reiterated: Buy
Price Target: $94 → $87
Current: $42.93
Upside: +102.66%
Ultragenyx Pharmaceutical
Oct 21, 2026
Reiterated: Buy
Price Target: $68 → $36
Current: $15.65
Upside: +130.03%
Rigel Pharmaceuticals
Oct 21, 2026
Reiterated: Hold
Price Target: $49
Current: $48.13
Upside: +1.81%
Oct 21, 2026
Reiterated: Buy
Price Target: $75
Current: $41.49
Upside: +80.77%
Oct 21, 2026
Reiterated: Buy
Price Target: $68
Current: $50.08
Upside: +35.78%
Oct 16, 2026
Reiterated: Hold
Price Target: $4
Current: $1.56
Upside: +156.41%
Sep 8, 2026
Reiterated: Buy
Price Target: $56
Current: $20.45
Upside: +173.84%
Aug 17, 2026
Reiterated: Buy
Price Target: $4
Current: $1.17
Upside: +241.88%
Aug 17, 2026
Reiterated: Buy
Price Target: $30
Current: $13.88
Upside: +116.14%
Aug 17, 2026
Reiterated: Buy
Price Target: $52 → $55
Current: $31.21
Upside: +76.23%
Aug 17, 2026
Reiterated: Hold
Price Target: $1
Current: $0.4354
Upside: +129.67%
Aug 17, 2026
Reiterated: Buy
Price Target: $12
Current: $3.73
Upside: +221.72%
Aug 17, 2026
Reiterated: Buy
Price Target: $30
Current: $9.21
Upside: +225.73%
Aug 7, 2026
Reiterated: Buy
Price Target: $12
Current: $11.82
Upside: +1.52%
Aug 7, 2026
Reiterated: Buy
Price Target: $14
Current: $11.46
Upside: +22.16%
Jan 23, 2026
Downgraded: Hold
Price Target: $3 → $0.5
Current: $0.0001
Upside: +499,900.00%
Jul 18, 2024
Reiterated: Buy
Price Target: $22
Current: $36.49
Upside: n/a
Mar 14, 2024
Upgraded: Buy
Price Target: $8 → $20
Current: $5.92
Upside: n/a